Seattle Cancer Care Alliance (SCCA) — Seattle, Washington

Public research footprint of Seattle Cancer Care Alliance (SCCA), compiled from the ClinicalTrials.gov public registry.

602

Registered studies

Active

Recruiting now

365

Completed

126

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor… · Non-Small Cell Lung Cancer Metastatic · Lymphoma, Diffuse Large B-Cell · Metastatic Renal Pelvis Urothelial Carcinoma

Recently updated registry entries

NCT07226843 — A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers (Recruiting)
NCT05424822 — A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in… (Active Not Recruiting)
NCT04770779 — A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Seattle Cancer Care Alliance (SCCA)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.